Cell Chemical Biology
25, 1337–1349.
APD-containing cyclolipodepsipeptides target mitochondrial function in hypoxic cancer cells.
2018
Jacobsen, K.M., Villadsen, N.L., Tørring, T., Nielsen, C.B., Salomón, T., Nielsen, M.M., Tsakos, M., Sibbersen, C., Scavenius, C., Nielsen, R., Christensen, E.I., Guerra, P.F., Bross,
P., Pedersen, J.S., Enghild, J.J., Johannsen, M., Frøkiær, J., Overgaard, J., Horsman, M.R., Busk, M. and Poulsen, T.B.
Notes: Hypoxic cancer cells constitute a major challenge in chemo- and radiotherapy. The researchers present evaluation of APD-CLD compounds that induce selective cell death in hypoxic cancer cells by impeding mitochondrial function. The RealTime-Glo™ Annexin V Apoptosis Assay, CellTiter-Blue® Cell Viability Assay, CellTox™ Green Real-Time Cytotoxicity Assay and GSH-Glo™ Glutathione Assay were used to assess mechanism of action. (5168)
Expand Full Notes »